ISSN: 2278-0238

薬学および生命科学における研究開発の国際ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

A Review on 3D Oral Printed Tablets: A Breakthrough Tool for Individualized Therapy According To Each Patient's Individual Circumstances with Different Techniques and Polymers Used For Formulation

Pujan V. Padsala, Harmish A Asodariya, Yash S Shah, Dip Ranpariya, Dr. Hiral Panchal

When treating patients from various origins with distinct cultures, metabolisms, and needs, interindividual variability is becoming a more widespread concern. Because dose modification typically relies on empirical techniques, there is a strong probability that undesirable side effects may manifest.The pharmaceutical industry is being revolutionized by three-dimensional (3D) printed pharmaceuticals as prospective instruments to create individualized therapies tailored to each patient's unique needs,taking into consideration their age, weight,pharmacogenetic,comorbidities, pharmacogenetic,and pharmacokinetic features. Only three of the various processes used in additive manufacturing, or 3D printing, are primarily employed in the 3D printing of pharmaceuticals: printing-based inkjet systems, nozzle-based deposition systems, and laser-based writing systems. Each method has a number of downsides, and the kinds of polymers thatare easily accessible don't necessarily have the best qualities for each medicine. The purpose of this study is to provide an overview of the current methods used in 3D printing medications, highlighting their advantages and shortcomings as well as the necessary polymers and medications for a successful print. Also covered will be the main applications
of these approaches.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。